Transcatheter interatrial shunt closure as a cure for migraine: Can it be justified by paradoxical embolism - Risk-driven criteria?

American Journal of the Medical Sciences

Volumn 337, Issue 3, 2009, Pages 179-181

  Rigatelli, Gianluca ^a   Cardaioli, Paolo ^a   Giordan, Massimo ^a   Dell'Avvocata, Fabio ^a   Braggion, Gabriele ^a   Chianaglia, Mauro ^a   Roncon, Loris ^a  

^a ROVIGO GENERAL HOSPITAL   (Italy)

Author keywords

Migraine; Patent foramen ovale; Stroke; Transcatheter closure

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CATHETERIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORBIDITY; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; RISK ASSESSMENT; TRANSCATHETER INTERATRIAL SHUNT CLOSURE; HEART CATHETERIZATION; METHODOLOGY; RISK; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EMBOLISM, PARADOXICAL; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MALE; MIGRAINE DISORDERS; RISK; STROKE;

EID: 63249100326     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31818599a7     Document Type: Article

References (27)

1. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli. Ann Intern Med 2003;139:753-760 (Pubitemid 38129075)
2. Anzola GP, Morandi E, Casilli F, et al. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler. Stroke 2004;35:2140-2144
3. Morandi E, Anzola GP, Casilli F, et al. Migraine: traditional or "innovative" treatment? A preliminary case-control study. Ped Cardiol 2005;26:231-233
4. Reisman M, Christofferson RD, Jesurum J. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol 2005;45:493-495 (Pubitemid 40222239)
5. Schwerzmann M, Wiher S, Nedeltchev K. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology 2004;2:1399-1401 (Pubitemid 38526056)
6. Olesen J. The international classification of headache disorders, 2nd edition. Cephalalgia 2004;24:1-160.
7. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the migraine disability assessment (MIDAS) score. Neurology 1999;53:988. (Pubitemid 29442114)
8. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients. J Interv Cardiol 2003;16:43-50. (Pubitemid 36293093)
9. Zanchetta M, Rigatelli G, Onorato E. Intracardiac echocardiography and transcranial Doppler ultrasound to guide closure of patent foramen ovale. J Invasive Cardiol 2003;15:93-96 (Pubitemid 36227877)
10. Zanchetta M, Rigatelli G, Pedon L, et al. Intracardiac echocardiography during catheter-based procedures: ultrasound system, examination technique, and image presentation. Echocardiography 2002;19: 501-507 (Pubitemid 35026184)
11. Zanchetta M, Rigatelli G, Pedon L, et al. Intracardiac echocardiography: gross anatomy and magnetic resonance correlations and validations. Intern J Cardiovascular Imaging 2005;21:391-401. (Pubitemid 41136090)
12. Sloan MA, Alexandrov AV, Tegeler CH. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2004;62:1468-1481 (Pubitemid 38608182)
13. Casaubon L, McLaughlin P, Webb G, et al. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci 2007;34:74-80. (Pubitemid 46423346)
14. Homma S, Sacco RL, Di Tullio MR, et al. Atrial anatomy in non-cardioembolic stroke patients: effect of medical therapy. J Am Coll Cardiol 2003;42:1066-1072 (Pubitemid 37108595)
15. Schwedt TJ, Dodick DW. Patent foramen ovale and migraine-bringing closure to the subject. Headache 2006;46:663.
16. Beda RD, Gill EA Jr. Patent foramen ovale: does it play a role in the pathophysiology of migraine headache? Cardiol Clin 2005;23:91-96
17. Anzola GP, Morandi E, Casilli F, et al. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients. Neurology 2006;66:765-767 (Pubitemid 43739842)
18. Sastry S, Riding G, Morris J, et al. Young Adult Myocardial Infarction and Ischemic Stroke: the role of paradoxical embolism and thrombophilia (The YAMIS Study). J Am Coll Cardiol 2006;48:686-691 (Pubitemid 44175709)
19. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology 1999;52:1622-1625 (Pubitemid 29220637)
20. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088
21. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746 (Pubitemid 34940229)
22. Santamarina E, Gonzalez-Alujas MT, Munoz V, et al. Stroke patients with cardiac atrial septal abnormalities: differential infarct patterns on DWI. J Neuroimaging 2006;16:334-340 (Pubitemid 44521384)
23. Giardini A, Donti A, Formigari R. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting. Am Heart J 2006;151:922.e1-e5.
24. Rigatelli G, Braggion G, Aggio S, et al. Primary patent foramen ovale closure to relieve severe migraine. Ann Intern Med 2006;144:458-459 (Pubitemid 46768181)
25. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404
26. Krumsdorf U, Ostermayer S, Billinger K, et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol 2004;43:302-309 (Pubitemid 38201160)
27. Amin Z, Hijazi ZM, Bass JL, et al. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004;63:496-502. (Pubitemid 39578516)